Kodera, R
Clinical Trials and Efficacy Phase 2 Trial in Obesity A pivotal 48-week phase 2 clinical trial evaluated retatrutides efficacy in 338 participants with obesity or overweight without diabetes
healthcare system: the cost
These medications require careful temperature control, and an insulated travel case can help protect them from heat exposure during transit
In this combined analysis, we observe that the degree of BMI loss depends strongly on sex, drug type, time on treatment and drug dosage, consistent with previous reports 11 , and has a relatively weak dependence on pre-treatment BMI (with higher starting BMI associated with greater BMI loss)
Access Limitations Define Americas Weight-Loss Divide More than 22 states now report adult obesity rates above 35%, and in several, including Mississippi, Louisiana, and West Virginia, rates approach or exceed 40%